The prevalence of markers of infection with hepatitis B virus in a mixed‐race Australian community
- 1 May 1989
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 150 (9) , 489-492
- https://doi.org/10.5694/j.1326-5377.1989.tb136593.x
Abstract
A seroepidemiological study of markers of infection with hepatitis B virus was conducted in Brewarrina, a mixed-race township in north-western New South Wales. Six hundred and forty-three subjects, who represented 41.5% of the town''s population, were screened for a range of serological markers of hepatitis B virus infection. Of the Aboriginal subjects, 72% had markers which indicated previous infection with hepatitis B virus, with 19.2% of subjects being identified as hepatitis B surface antigen (HBsAg)-seropositive. In the non-Aboriginal subjects, the prevalence of infection with makers of hepatitis B virus was 13.1%, with 2.2% of subjects being HBsAg-seropositive. The marker prevalences for Aboriginal and non-Aboriginal subjects in the 15- to 19-year-old age-group were 86.7% and 28%, respectively. The prevalence of hepatitis B virus infection in the total non-Aboriginal sample was higher than it is in the general Australian blood-donor population. The extent to which hepatitis B virus infection may result from cross-infection between coexisting "high-risk" and "low-risk" population groups is speculative. Furthermore, the risk of infection to non-Aborigines is unlikely to be spread evenly across the non-Aboriginal community. The cost of vaccine remains high, and until further data become available, mass vaccination of the population probably ius not warranted. Initially, control measures should concentrate on the reduction of hepatitis B virus infection in the Aboriginal population and in non-Aboriginal households which contain a HBsAg-seropositive member.This publication has 12 references indexed in Scilit:
- Hepatitis A and B in Australian Aboriginals living in an urban communityJournal of Gastroenterology and Hepatology, 1987
- OCCURRENCE AND DISTRIBUTION OF HEPATITIS B INFECTION IN THE ABORIGINAL POPULATION OF WESTERN AUSTRALIAAustralian and New Zealand Journal of Medicine, 1987
- Postexposure Prophylaxis of Hepatitis BAnnals of Internal Medicine, 1984
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983
- Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier MothersThe Journal of Infectious Diseases, 1983
- Incidence of Hepatitis B Virus Infections in Preschool Children in TaiwanThe Journal of Infectious Diseases, 1982
- DEMONSTRATION OF PREVIOUSLY UNDETECTED HEPATITIS B VIRAL DETERMINANTS IN AN AUSTRALIAN ABORIGINAL POPULATION BY MONOCLONAL ANTI-HBs ANTIBODY RADIOIMMUNOASSAYSThe Lancet, 1982
- EFFICACY OF HEPATITIS B VACCINE IN PREVENTION OF EARLY HBsAg CARRIER STATE IN CHILDREN Controlled Trial in an Endemic Area (Senegal)The Lancet, 1981
- VIRAL HEPATITIS A AND B; A SEROEPIDEMIOLOGICAL STUDY OF A NON‐HEPATITIC SYDNEY POPULATIONThe Medical Journal of Australia, 1980
- Vertical Transmission of Hepatitis B Antigen in TaiwanNew England Journal of Medicine, 1975